The Latest Cardiac and Vascular News
Closing the gap between industry and academia to place patients directly at the center of research efforts. , Jan. 6, 2022 /PRNewswire/ – LQT Therapeutics, a privately-held biopharmaceutical company advancing novel SGK1 kinase therapeutics, today announced that the project “SILENCE-LQTS: SGK1 inhibition as a novel therapeutic approach in Long QT syndrome” was selected for […]
SAN FRANCISCO and BETHPAGE, N.Y., Jan. 5, 2022 /PRNewswire/ — Housatonic Partners, a growth-oriented private equity firm focused on investing in market-leading services companies, announced a strategic growth investment in Mobile Vascular Physicians (“MVP”), a New York-based concierge medical practice that utilizes a specialized, mobile approach to provide vascular and interventional radiology services to residents […]
SNOQUALMIE, Wash.–(BUSINESS WIRE)–Spacelabs Healthcare, a division of OSI Systems, Inc. (the “Company” or “OSI Systems”) (NASDAQ: OSIS), today announced the release of CardioPulse™ Go and CardioPulse™ Prime resting Electrocardiograph (ECG) devices. “Workflow fit is a critical factor for clinicians when choosing resting ECG devices,” said Spacelabs President Shalabh Chandra. “Keeping […]
COSIRA-II Trial Designed to Study the Neovasc Reducer™ for Patients with Refractory Angina VANCOUVER and MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced enrollment of the first patient in the COSIRA-II clinical trial. COSIRA-II (COronary SInus Reducer for the Treatment of Refractory Angina) is a pivotal trial […]
LAGUNA HILLS, Calif., Jan. 4, 2022 /PRNewswire/ — Adagio Medical, Inc., a leading innovator in catheter ablation technologies for atrial fibrillation (AF) and ventricular tachycardia (VT), today announced first-in-human cases of pulsed field cryoablation (PFCA) for the treatment of atrial fibrillation (AF). The cases were performed at Medicover Hospital, Warsaw, Poland by Dr. Pawel Derejko, Head […]
PLANO, Texas, Jan. 5, 2022 /PRNewswire/ — MediLynx Cardiac Monitoring, LLC (dba MediLynx Arrhythmia Diagnostics) today announced that its parent company, MEDICALgorithmics S.A. (WSE: MDG) has received a broad patent (US Patent No. 11,183,305) for continuous (full-disclosure) ECG streaming, analysis and monitoring from a remote location. “Traditional Mobile Cardiac Telemetry (MCT) devices upload […]
Amended study design provides immediate access and clinical benefits for all patients and becomes the first global IDE study for PA pressure-guided heart failure management LISLE, Ill., Jan. 5, 2022 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), today announced the […]
3D models will be used to simulate complex valve repairs in preparation for surgical interventions BOSTON, Jan. 5, 2022 /PRNewswire/ — BIOMODEX®, the leader in biorealistic haptic simulators for physician training and rehearsals, and the Montreal Heart Institute (MHI), a world-renowned, ultra-specialized cardiology center, announced they are partnering to develop a new cardiovascular training solution to […]
CAMBRIDGE, Mass., Jan. 5, 2022 /PRNewswire/ — Anthos Therapeutics, a late-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today announced the appointment of David McIntyre as Chief Financial Officer. Mr. McIntyre will assume responsibility for the company’s finance and investor relation functions, and joins Anthos as its lead product candidate, abelacimab, expects […]
WEST CHESTER, Pa., Jan. 4, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce the final closing of their $5.95M Series A financing, which includes conversion of all existing convertible notes. The A round was led by Florida based New World Angels (https://www.newworldangels.com/), followed by DeepWork Capital (https://www.deepworkcapital.com/) and Ocean Azul Partners (https://oceanazulpartners.com/). VESTECK received significant support […]
